Belite Bio (BLTE) Enterprise Value (2022 - 2026)

Belite Bio's Enterprise Value history runs 5 years deep, the most recent figure standing at -$155.1 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 328.23% year-over-year to -$155.1 million; the TTM figure through Dec 2025 stood at -$155.1 million (down 328.23% YoY), while the FY2025 annual figure was -$155.1 million, down 328.23% from the prior year.
• Enterprise Value for Q4 2025 stood at -$155.1 million, up from -$157.0 million in the prior quarter.
• The five-year high for Enterprise Value was -$17.3 million in Q4 2021, with the low at -$157.0 million in Q3 2025.
• The 5-year median for Enterprise Value is -$65.1 million (2022), against an average of -$82.7 million.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 58.91% in 2024, then slumped 328.23% in 2025.
• Belite Bio's Enterprise Value stood at -$17.3 million in 2021, then sank by 142.67% to -$42.1 million in 2022, then slumped by 109.45% to -$88.2 million in 2023, then jumped by 58.91% to -$36.2 million in 2024, then sank by 328.23% to -$155.1 million in 2025.
• Business Quant data shows BLTE's Enterprise Value at -$155.1 million in Q4 2025, -$157.0 million in Q3 2025, and -$36.2 million in Q4 2024.